Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
April 1, 2022
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2022
Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
March 4, 2022
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 2, 2022
Adicet Bio to Participate in Guggenheim 2022 Oncology Conference
December 10, 2021
Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
December 8, 2021
Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock
December 7, 2021
Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock
December 6, 2021
Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy
November 29, 2021
Adicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkin’s Lymphoma
November 18, 2021
Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page next ›
  • Last page last »
Displaying 51 - 60 of 110

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2023 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.